The Patent Finder

Firststring Research, Inc.

Also on record
Records under this name other than patents Firststring Research, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Firststring Research, Inc.

PatentTitleStatus Expires Confidence
US 9,161,984Formulations and Methods of Use for Alpha Connexin C-Terminal (ACT) Peptides
Formerly held
In force
 · Low confidence
In forceLow confidence
US 10,632,173Formulations and Methods of Use for Alpha Connexin C-Terminal (ACT) Peptides
Formerly held
In force
 · Low confidence
In forceLow confidence
US 11,524,049Formulations and Methods of Use for Alpha Connexin C-Terminal (ACT) Peptides
Formerly held
In force
 · Low confidence
In forceLow confidence
US 12,128,086Formulations and Methods of Use for Alpha Connexin C-Terminal (ACT) Peptides
Formerly held
In force
 · Low confidence
In forceLow confidence
US 12,138,293Peptide Formulations and Ophthalmic Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,846,605Formulations and Methods of Use for Alpha Connexin C-Terminal (ACT) Peptides
Formerly held
Lapsed on the fee record
Ended Sep 30, 2026 · Medium confidence
Lapsed on the fee recordEnded Sep 30, 2026Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited